FDA Adverse Event Malfunction Summary report: N

BD BBL¿ COLUMBIA CNA AGAR WITH 5% SHEEP BLOOD

MDR report key: 12163778 · Received July 13, 2021

Report

Report Number
1119779-2021-01164
Event Type
Malfunction
Date Received
July 13, 2021
Date of Event
June 14, 2021
Report Date
January 5, 2022
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
JSJ
UDI-DI
10382902213656
PMA / PMN Number
PREAMENDMENT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY DURING MANUFACTURING OF MATERIAL 221353, MEDIA IS FORMULATED AND SENT THROUGH A HIGH TEMPERATURE SHORT TIME STERILIZER TO REMOVE BIOBURDEN. THE PETRI DISHES ARE SUBJECTED TO UV RADIATION TO DECREASE BIOBURDEN. THE PETRI DISHES ARE FILLED IN A POSITIVE PRESSURE HEPA FILTERED ENVIRONMENT. THE FILLED PLATES ARE COOLED AND IMMEDIATELY WRAPPED INTO SLEEVES TO DECREASE THE INTRODUCTION OF MICROBES. SLEEVES ARE THEN PACKAGED INTO CARTONS AND THEN TRANSFERRED TO A REFRIGERATED TRUCK (2 TO 8 DEGREES C) FOR SHIPMENT TO THE DISTRIBUTOR. BD DISTRIBUTORS ARE PROVIDED WITH THE STORAGE GUIDELINES FOR THE SHIPPING AND HANDLING OF BD MEDIA OF 2 TO 8 DEGREES C IN A DARK PLACE. THE BATCH HISTORY RECORD FOR BATCH 1099171 WAS SATISFACTORY AT TIME OF RELEASE AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. THE RELEASE TESTING THAT IS PERFORMED ON THIS PRODUCT DOES INCLUDE BIOBURDEN TESTING. A SAMPLE OF PLATES ARE INCUBATED AT 25 DEGREES C AND AT 35 DEGREES C FOR APPROXIMATELY 72 HOURS. ALL BIOBURDEN TESTING PERFORMED ON THIS BATCH WAS SATISFACTORY PER BD INTERNAL PROCEDURES. AFFECTED PRODUCT DOES NOT HAVE ANY STERILITY CLAIMS; THE PRODUCT IS TESTED FOR BIOBURDEN PRIOR TO RELEASE TO ENSURE THAT IT CONFORMS TO PRODUCT SPECIFICATIONS. HOWEVER, THIS DOES NOT ENSURE THAT THE END-USER WILL NOT RECEIVE A CONTAMINATED PLATE. THE COMPLAINT HISTORY WAS REVIEWED, AND NO OTHER COMPLAINTS HAVE BEEN TAKEN ON BATCH 1099171. RETENTION SAMPLES FROM BATCH 1099171 WERE NOT AVAILABLE FOR INSPECTION. FOUR PHOTOS WERE RECEIVED FOR INVESTIGATION. ONE PHOTO SHOWS A SLEEVE FROM BATCH 1099171 WITH TWO PLATES AT THE TOP THAT APPEAR TO BE DARKENED FROM POSSIBLE MICROBIAL GROWTH. ONE PHOTO SHOWS THREE SLEEVES FROM BATCH 1099171 AND TWO OF THE SLEEVES HAVE DARKENED PLATES FROM POSSIBLE MICROBIAL GROWTH. THE THIRD PHOTO SHOWS THE TOP OF SEVEN SLEEVES FROM BATCH 1099171 (TIME STAMPS NOT READABLE) AND SOME TOP PLATES VISIBLE ARE DARKENED WITH POSSIBLE MICROBIAL GROWTH. THE LAST PHOTO SHOWS THE SIDE OF A SLEEVE OF PLATES FROM BATCH 1099171 WITH ALL PLATES SHOWING A DARK BROWN-RED COLOR. NO RETURN SAMPLES WERE RECEIVED FOR INVESTIGATION. WHILE IT IS POSSIBLE THAT MICROBIAL GROWTH CAN CAUSE THE DARKENING OF THE PLATES IN THE PHOTOS PROVIDED, NO MICROBIAL GROWTH COULD BE OBSERVED FROM THE PHOTOS. THIS COMPLAINT CAN ONLY BE CONFIRMED FOR COLOR VARIATION BY THE PHOTOS. BD WILL CONTINUE TO TREND COMPLAINTS FOR APPEARANCE. BASED ON THE LOW DEFECT RATE FOR THIS BATCH, NO ACTIONS ARE PLANNED AT THIS TIME. H3 OTHER TEXT : SEE H10.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD BBL¿ COLUMBIA CNA AGAR WITH 5% SHEEP BLOOD CONTAMINATION WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT CONTAMINATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD BBL¿ COLUMBIA CNA AGAR WITH 5% SHEEP BLOOD CONTAMINATION WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT CONTAMINATION.

Additional Manufacturer Narrative · 1

MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. DEVICE MANUFACTURE DATE: UNKNOWN. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT WHILE USING BD BBL" COLUMBIA CNA AGAR WITH 5% SHEEP BLOOD CONTAMINATION WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "IT WAS REPORTED THAT CONTAMINATION."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1059953 BD BBL¿ COLUMBIA CNA AGAR WITH 5% SHEEP BLOOD CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL JSJ BECTON, DICKINSON & CO. (SPARKS) 221365 1099171 10382902213656

Patients

Seq Age Sex Outcome Treatment
1 Unknown